Literature DB >> 18078808

Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX.

Congsheng Cheng1, Jie Dong, Lihong Yao, Aijun Chen, Runqing Jia, Lifang Huan, Jianqiang Guo, Yuelong Shu, Zhiqing Zhang.   

Abstract

New therapeutics are urgently needed for the treatment of pandemic influenza caused by H5N1 influenza virus mutants. Aptamer was a promising candidate for treatment and prophylaxis of influenza virus infections. In this study, systemic evolution of ligands through exponential enrichment (SELEX) was used to screen DNA aptamers targeted to recombinant HA1 proteins of the H5N1 influenza virus. After 11 rounds of selection, DNA aptamers that bind to the HA1 protein were isolated and shown to have different binding capacities. Among them, aptamer 10 had the strongest binding to the HA1 protein, and had an inhibitory effect on H5N1 influenza virus, as shown by the hemagglutinin and MTT assays. These results should aid the development of new drugs for the prevention and control of influenza virus infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078808     DOI: 10.1016/j.bbrc.2007.11.183

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  DNA aptamers against the receptor binding region of hemagglutinin prevent avian influenza viral infection.

Authors:  Seung Kwan Choi; Changjin Lee; Kwang Soo Lee; Soo-Young Choe; In Pil Mo; Rho Hyun Seong; Seokmann Hong; Sung Ho Jeon
Journal:  Mol Cells       Date:  2011-11-03       Impact factor: 5.034

2.  Emerging Technologies for the Treatment of COVID-19.

Authors:  Hossein Aghamollaei; Rahim Sarvestani; Hamid Bakherad; Hamed Zare; Paul C Guest; Reza Ranjbar; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Neutralizing DNA aptamers against swine influenza H3N2 viruses.

Authors:  Manoosak Wongphatcharachai; Ping Wang; Shinichiro Enomoto; Richard J Webby; Marie R Gramer; Alongkorn Amonsin; Srinand Sreevatsan
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

4.  Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing.

Authors:  Margaret J Lange; Tarun K Sharma; Angela S Whatley; Linda A Landon; Michael A Tempesta; Marc C Johnson; Donald H Burke
Journal:  Mol Ther       Date:  2012-09-04       Impact factor: 11.454

5.  Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis.

Authors:  Changtai Zhu; Jinming Liu; Yang Ling; Hua Yang; Zhonghua Liu; Ruijuan Zheng; Lianhua Qin; Zhongyi Hu
Journal:  BMC Infect Dis       Date:  2012-04-20       Impact factor: 3.090

6.  Development, screening, and analysis of DNA aptamer libraries potentially useful for diagnosis and passive immunity of arboviruses.

Authors:  John G Bruno; Maria P Carrillo; Alicia M Richarte; Taylor Phillips; Carrie Andrews; John S Lee
Journal:  BMC Res Notes       Date:  2012-11-13

7.  Two DNA aptamers against avian influenza H9N2 virus prevent viral infection in cells.

Authors:  Yuewei Zhang; Ziqiang Yu; Fei Jiang; Ping Fu; Junjun Shen; Wenxue Wu; Jinxiang Li
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

8.  An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein.

Authors:  Clare Nicol; Özlem Cesur; Sophie Forrest; Tamara A Belyaeva; David H J Bunka; G Eric Blair; Nicola J Stonehouse
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

9.  Multiplexed microcolumn-based process for efficient selection of RNA aptamers.

Authors:  David R Latulippe; Kylan Szeto; Abdullah Ozer; Fabiana M Duarte; Christopher V Kelly; John M Pagano; Brian S White; David Shalloway; John T Lis; Harold G Craighead
Journal:  Anal Chem       Date:  2013-02-27       Impact factor: 6.986

10.  Proposed lead molecules against Hemagglutinin of avian influenza virus (H5N1).

Authors:  Tannistha Nandi
Journal:  Bioinformation       Date:  2008-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.